Dexmedetomidine comparison with Labetalol for induced hypotensionduring functional endoscopic sinus surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/06/043087
- Lead Sponsor
- Government Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
American Society of Anesthesiologists (ASA) physical status I–II and age between 20 and 60 years patients scheduled for elective FESS under general anesthesia.
Exclusion Criteria
age = 20 years
known allergy to the anesthetic agents
patients with compromised renal hepatic and cardiac function
hypertension
coagulation disorders or patients on medications affecting coagulation system
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the time to achieve the target MAP with infusion doses of study drugs.Timepoint: MAP will be recorded before starting the bolus and infusion of the study drug (baseline measurement, one minute after endotracheal intubation, and then every 15 minutes throughout the procedure) <br/ ><br>
- Secondary Outcome Measures
Name Time Method To assess the quality of the surgical field, adverse effects and recovery characteristics <br/ ><br>Timepoint: After FESS Visual Analogue Scale score seen after every 15 minutes till score is more than 4 <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>